Catalyst Wire Dossier Catalyst Wire Dossier

Vedolizumab

vedolizumab · Takeda
Drug timelines are a Plus or Pro feature.

83 regulatory and trial events tracked for Vedolizumab, covering 2014-07-18 to 2026-06-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab [Phase 3]

See pricing